[Comment] Expanding the benefits of HPV vaccination to boys and men
Human papillomavirus (HPV) is the most common sexually transmitted infection. It affects 80% of the population, with the initial infection usually occurring between 15 and 24 years of age. Persistent infection with high-risk oncogenic HPV genotypes, primarily types 16 and 18, is the cause of almost all cervical cancers.1 HPV is also thought to cause about 95% of anal cancers, 75% of oropharyngeal cancers, 75% of vaginal cancers, 70% of vulvar cancers, and 60% of penile cancers.2 Low-risk or non-oncogenic genotypes (eg, types 6 and 11) cause anogenital warts, low-grade cervical disease, and recurrent respiratory papillomatosis.
Source: LANCET - Category: Journals (General) Authors: Kathleen M Schmeler, Erich M Sturgis Tags: Comment Source Type: research
More News: Anal Cancer | Boys | Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | General Medicine | Genital Warts | Human Papillomavirus (HPV) | Oropharyngeal Cancer | Papillomatosis | Penile Cancer | Respiratory Medicine | STDs | Vaccines | Vaginal Cancer | Vulvar Cancer | Warts